Company: CERO
Filing Date: 2025-11-20
Form Type: 424B3
Source: 0001213900-25-113118
Chunk: 73

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-20
Form: 424B3
Chunk 73
---
4, the stockholders approved an increase
in the number of shares available for issuance under the 2024 Plan and the number of shares that may be issued pursuant to incentive stock
options, by an additional 1,000 shares each. At a special meeting of stockholders on November 11, 2024, the stockholders approved an increase
in the number of shares available for issuance under the 2024 Plan and the number of shares that may be issued pursuant to incentive stock
options, by an additional 10,423 shares each. The 2024 Plan has an evergreen provision that allows for an annual increase in the number
of shares available for issuance under the 2024 Plan to be added on the first day of January, starting with January 1, 2025, in an amount
equal to the lesser of (i) 5% of the fully diluted shares of our Common Stock on the immediately preceding December 31 or (ii) such number
of shares as determined by our board in each case subject to adjustment in the event of a stock split, stock dividend or other change
in our capitalization. On January 1, 2025, the number of shares reserved under the 2024 Plan was increased by 5% of the fully diluted
shares of our common stock on the immediately preceding December 31, or 9,485 shares. On May 29, 2025, at the Company’s annual meeting,
the stockholders approved an amendment to the 2024 Plan to increase the number of shares issuable thereunder by an additional 100,000
shares of Common Stock.

On March 25, 2024, stockholders
approved the 2024 Employee Stock Purchase Plan (the “2024 ESPP”), with initial reserves of 255 shares of common stock. The
2024 ESPP became effective on February 14, 2024. The 2024 ESPP also has an evergreen provision. On January 1, 2025, the reserve increased
by 510 shares. No awards have been granted under the 2024 ESPP as of September 30, 2025.

On March 4, 2025, the Company’s
Board of Directors granted an aggregate of 20,313 stock options under the 2024 Plan, to board members, exercisable on the date of grant
at $28.60 per share with a ten-year term and vest over a requisite service period, which is